tradingkey.logo
tradingkey.logo

Zenas Biopharma Announces Proposed Concurrent Public Offerings Of Convertible Senior Notes Due 2032 And Common Stock

ReutersMar 26, 2026 8:49 PM

- Zenas Biopharma Inc ZBIO.O:

  • ZENAS BIOPHARMA ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF CONVERTIBLE SENIOR NOTES DUE 2032 AND COMMON STOCK

  • ZENAS BIOPHARMA INC - PROCEEDS TO SUPPORT OBEXELIMAB U.S. LAUNCH, PIPELINE ADVANCEMENT, AND GENERAL CORPORATE PURPOSES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI